Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial
- 31 July 1996
- Vol. 14 (10) , 982-986
- https://doi.org/10.1016/0264-410x(96)00042-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Hepatitis A vaccineCurrent Opinion in Infectious Diseases, 1995
- Immunogenicity of new virosome influenza vaccine in elderly peopleThe Lancet, 1994
- Inactivated hepatitis A vaccinesPublished by American Medical Association (AMA) ,1994
- Inactivated virosome hepatitis A vaccineThe Lancet, 1994
- Vaccination against hepatitis A: Control 3 years after the first vaccinationVaccine, 1992
- Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccineVaccine, 1992
- Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.Journal of Clinical Investigation, 1992
- Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findingsVaccine, 1992
- Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigensVaccine, 1992
- The Physicochemical Properties of Infectious Hepatitis A VirionsJournal of General Virology, 1981